Anti-Human CD30 Ligand
- -
- -
Antibody DetailsProduct DetailsReactive Species Human Host Species Goat Immunogen NS0-Derived Human CD30 Ligand Extracellular Domain Endotoxin Level <1.0 EU/µg as determined by the LAL method Formulation This antigen affinity purified polyclonal antibody has been 0.2 µm filtered and lyophilized from modified Dulbecco’s phosphate buffered saline (1X PBS) pH 7.2 – 7.4 containing 5.0% w/v trehalose with no calcium, magnesium, or preservatives present. State of Matter Lyophilized Storage and Handling The lyophilized antigen affinity purified polyclonal antibody can be stored desiccated at -20°C to -70°C for twelve months from date of receipt. The reconstituted antibody can be stored for at least four weeks at 2-8°C. For long-term storage of the reconstituted antibody, aseptically aliquot into working volumes and store at -20°C to -70°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles. No detectable loss of activity was observed after six months. Country of Origin USA Shipping Next Day Ambient RRIDAB_2828422 Applications and Recommended Usage? Quality Tested by Leinco Flow Cytometry: It is recommended to use the indirect method for signal enhancement when enumerating cells expressing CD30 Ligand. A suggested method would be to stain cells expressing CD30 Ligand with 0.25 µg/106 cells in a total staining volume of 100 µl followed by PN:G641. Western Blotting: To detect Human CD30 Ligand this polyclonal antibody can be used at a concentration of 0.1-0.2 µg/ml. This polyclonal antibody should be used in conjunction with compatible second-step reagents such as PN:G505 and a chromogenic substrate such as PN:T343. The detection limit for Human CD30 Ligand is .5 ng/lane under either reducing or non-reducing conditions. The sensitivity of detection may increase up to 50 fold when a chemiluminescent substrate is used. A suitable Western blotting control is PN:C1334. Additional Applications Reported In Literature ? Immunohistochemistry: Suitable for use at concentration of 0.1-15 µg/mL. CyTOF-ready: Ready to be labeled using established conjugation methods. No BSA or other carrier proteins that could interfere with conjugation. Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionSpecificity Goat Anti-Human CD30 Ligand recognizes Human CD30 Ligand. This antigen affinity purified polyclonal antibody was purified using a proprietary chromatographic technique that includes covalently immobilizing the antigen proteins or peptides to agarose based beads. This purification method enhances specificity, reduces nonspecific binding of extraneous IgG and provides you with the most reliable reagent available for your early discovery research. Background The CD30 ligand is a type II transmembrane glycoprotein of the tumor necrosis factor ligand superfamily. CD30L is expressed on the cell surface of activated T cells, B cells, and monocytes. Recombinant CD30L has been shown to co-stimulate T cells and to act as a mitogen for Hodgkin's disease derived cell lines. The receptor for CD30L, CD30/ TNFRSF8/CD153, is a type I cytokine receptor that is highly expressed by activated T cells, Hodgkin and Reed- Sternberg (H-RS) cells, and anaplastic large cell lymphoma cells. CD30 ligation by CD30L mediates pleiotropic effects including cell proliferation, activation, differentiation and cell death by apoptosis. Antigen DetailsPubMed NCBI Gene Bank ID UniProt.org References & Citations1. Croager, EJ. et al. (1997) Biochim. Biophys. Acta. 1353:231 2. Gruss, HJ. et al. (1994) Blood 83:1521 3. Wendtner, CM. et al. (1995) Cancer Res. 55:4157 4. Fischer, M. et al. (2006) J. Clin. Invest. 116:2748 5. Blazar, BR. et al. (2004) J. Immunol. 173:2933 Technical ProtocolsCyTOF®    |
Related Products
- -
- -
Prod No. | Description |
|---|---|
C1367 | |
C1455 | |
C1476 | |
C1354 |
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
